	US 11,986,520 B2
	Method for the prophylaxis or treatment of coronavirus infection using an immunomodulator and vaccine compositions comprising the same
Yu-Shen Hsu, Taipei (TW); Ssu-Wei Kang, Taipei (TW); and Ming-I Chang, Taipei (TW)
Assigned to ADVAGENE BIOPHARMA CO., LTD., Taipei (TW)
Filed by ADVAGENE BIOPHARMA CO., LTD., Taipei (TW)
Filed on May 7, 2021, as Appl. No. 17/314,135.
Claims priority of provisional application 63/022,017, filed on May 8, 2020.
Prior Publication US 2021/0346491 A1, Nov. 11, 2021
Int. Cl. A61K 39/215 (2006.01); A61P 31/12 (2006.01); A61K 39/00 (2006.01)

CPC A61K 39/215 (2013.01) [A61K 2039/5252 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/55544 (2013.01)]

5 Claims

1. A method for treatment or prophylaxis of coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an immunomodulator as the sole active ingredient, wherein the immunomodulator is LTh(αK).